000 01579 a2200421 4500
005 20250514043256.0
264 0 _c20030410
008 200304s 0 0 eng d
022 _a0167-0115
024 7 _a10.1016/s0167-0115(02)00152-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStark, Alexander
245 0 0 _aSomatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
_h[electronic resource]
260 _bRegulatory peptides
_cOct 2002
300 _a97-102 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aCyclic AMP Response Element-Binding Protein
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Interactions
650 0 4 _aGlucagon
_xantagonists & inhibitors
650 0 4 _aGlucagon-Like Peptide 1
650 0 4 _aInsulin
_xmetabolism
650 0 4 _aInsulin Secretion
650 0 4 _aInsulinoma
650 0 4 _aPancreatic Neoplasms
650 0 4 _aPeptide Fragments
_xantagonists & inhibitors
650 0 4 _aProtein Precursors
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aSomatostatin
_xpharmacology
650 0 4 _aTranscription Factors
_xdrug effects
650 0 4 _aTumor Cells, Cultured
700 1 _aMentlein, Rolf
773 0 _tRegulatory peptides
_gvol. 108
_gno. 2-3
_gp. 97-102
856 4 0 _uhttps://doi.org/10.1016/s0167-0115(02)00152-0
_zAvailable from publisher's website
999 _c12101146
_d12101146